AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

Autor: Di Micco, Antonia, Frera, Gianluca, Lugrin, Jérôme, Jamilloux, Yvan, Hsu, Erh-Ting, Tardivel, Aubry, De Gassart, Aude, Zaffalon, Léa, Bujisic, Bojan, Siegert, Stefanie, Quadroni, Manfredo, Broz, Petr, Henry, Thomas, Hrycyna, Christine A., Martinon, Fabio

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2016 Aug 01. 113(32), E4671-E4680.

Externí odkaz: https://www.jstor.org/stable/26471374

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pomalidomide-based treatment in relapsed refractory multiple myeloma: Analysis of baseline characteristics and safety profile of patients who died in the European post approval safety study

Autor: Gamberi, Barbara, Abildgaard, Niels, Ramirez Payer, Angel, Kyriakou, Charalampia, Schmidt Hieber, Martin, Di Raimondo, Francesco, Kueenburg, Elisabeth, Di Micco, Antonia, Rosettani, Barbara, Atiba-Davies, Margaret, Bacon, Pamela, Plesner, Torben

Publikováno v: Gamberi, B, Abildgaard, N, Ramirez Payer, A, Kyriakou, C, Schmidt Hieber, M, Di Raimondo, F, Kueenburg, E, Di Micco, A, Rosettani, B, Atiba-Davies, M, Bacon, P & Plesner, T 2019, ' Pomalidomide-based treatment in relapsed refractory multiple myeloma: Analysis of baseline characteristics and safety profile of patients who died in the European post approval safety study ', 24th European Hematology Association Congress (EHA), Amsterdam, Netherlands, 13/06/2019-16/06/2019 . < https://library.ehaweb.org/eha/2019/24th/267035/barbara.gamberi.pomalidomide-based.treatment.in.relapsed.refractory.multiple.html?f=listing%3D3%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D2 >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::ae8641b5cfb6c977a6a8573461d7b6c3
https://portal.findresearcher.sdu.dk/da/publications/20c5a5da-2d04-45b2-9851-0f0ab5cdaa19

EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING

Autor: Schmidt-Hieber, Martin, Abildgaard , Niels, Gamberi, Barbara, Di Raimondo, Francesco, Ramirez Payer, Angel, Kyriakou, Charalampia, Froen, Hege Froen, Izarra, Antonio Izarra, Kueenburg, Elisabeth, Di Micco, Antonia, Rosettani, Barbara, Bacon, Pamela, Atiba-Davies, Margaret, Plesner, Torben

Publikováno v: Schmidt-Hieber, M, Abildgaard, N, Gamberi, B, Di Raimondo, F, Ramirez Payer, A, Kyriakou, C, Froen, H F, Izarra, A I, Kueenburg, E, Di Micco, A, Rosettani, B, Bacon, P, Atiba-Davies, M & Plesner, T 2018, ' EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING ', EHA Learning Center . < https://learningcenter.ehaweb.org/eha/2018/stockholm/215013/martin.schmidt-hieber.european.post-approval.safety.study.in.relapsed.or.html >
Schmidt-Hieber, M, Abildgaard, N, Gamberi, B, Di Raimondo, F, Ramirez Payer, A, Kyriakou, C, Froen, H F, Izarra, A I, Kueenburg, E, Di Micco, A, Rosettani, B, Bacon, P, Atiba-Davies, M & Plesner, T 2018, ' EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING ', European Hematology Association 23rd congress EHA 2018, Stockholm, Sweden, 14/06/2018-17/06/2018 . < https://learningcenter.ehaweb.org/eha/2018/stockholm/215013/martin.schmidt-hieber.european.post-approval.safety.study.in.relapsed.or.html >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::96ce92d0b24c08bc9cf2bdb7ebae8dc3
https://learningcenter.ehaweb.org/eha/2018/stockholm/215013/martin.schmidt-hieber.european.post-approval.safety.study.in.relapsed.or.html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.